ATE526980T1 - Zusammensetzungen und verfahren zur heilung von nervengeweben - Google Patents
Zusammensetzungen und verfahren zur heilung von nervengewebenInfo
- Publication number
- ATE526980T1 ATE526980T1 AT99955594T AT99955594T ATE526980T1 AT E526980 T1 ATE526980 T1 AT E526980T1 AT 99955594 T AT99955594 T AT 99955594T AT 99955594 T AT99955594 T AT 99955594T AT E526980 T1 ATE526980 T1 AT E526980T1
- Authority
- AT
- Austria
- Prior art keywords
- healing
- compositions
- methods
- nervous tissue
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Processing Of Meat And Fish (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP6748A AUPP674898A0 (en) | 1998-10-27 | 1998-10-27 | A method of treatment |
| PCT/AU1999/000931 WO2000024413A1 (en) | 1998-10-27 | 1999-10-27 | A method of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE526980T1 true ATE526980T1 (de) | 2011-10-15 |
Family
ID=3810964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99955594T ATE526980T1 (de) | 1998-10-27 | 1999-10-27 | Zusammensetzungen und verfahren zur heilung von nervengeweben |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7341997B2 (de) |
| EP (1) | EP1133309B1 (de) |
| AT (1) | ATE526980T1 (de) |
| AU (1) | AUPP674898A0 (de) |
| CA (1) | CA2346219C (de) |
| WO (1) | WO2000024413A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887674B1 (en) | 1998-04-13 | 2005-05-03 | California Institute Of Technology | Artery- and vein-specific proteins and uses therefor |
| US6864227B1 (en) | 1998-04-13 | 2005-03-08 | California Institute Of Technology | Artery-and vein-specific proteins and uses therefor |
| AUPP674898A0 (en) | 1998-10-27 | 1998-11-19 | Walter And Eliza Hall Institute Of Medical Research, The | A method of treatment |
| US7381410B2 (en) | 2003-03-12 | 2008-06-03 | Vasgene Therapeutics, Inc. | Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| EP1605961A4 (de) | 2003-03-12 | 2009-11-11 | Vasgene Therapeutics Inc | Polypeptid-verbindungen zur hemmung der angiogenese und des tumorwachstums |
| KR20120123619A (ko) | 2004-03-12 | 2012-11-08 | 바스진 테라퓨틱스, 인크. | 혈관형성 및 종양 성장을 억제하기 위한 폴리펩티드 화합물 |
| WO2005090406A2 (en) | 2004-03-12 | 2005-09-29 | Vasgene Therapeutics, Inc. | Antibodies binding to ephb4 for inhibiting angiogenesis and tumor growth |
| NZ553273A (en) * | 2004-09-08 | 2009-11-27 | Univ Melbourne | Treating gliosis, glial scarring, inflammation or inhibition of a xonal growth in the nervous system with an antagonist of EphA4-mediated signalling |
| AU2005282217B2 (en) * | 2004-09-08 | 2012-05-31 | The University Of Melbourne | Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor |
| WO2006034455A2 (en) | 2004-09-23 | 2006-03-30 | Vasgene Therapeutics, Inc. | Polipeptide compounds for inhibiting angiogenesis and tumor growth |
| CN102083861B (zh) | 2007-08-13 | 2016-04-13 | 瓦斯基因治疗公司 | 使用结合EphB4的人源化抗体的癌症治疗 |
| PH12013501137A1 (en) | 2010-12-08 | 2021-06-02 | Abbvie Stemcentrx Llc | Novel modulators and methods of use |
| RU2016119491A (ru) | 2013-11-04 | 2017-12-11 | Пфайзер Инк. | Конъюгаты антитела к efna4 с лекарственным средством |
| JP6877419B2 (ja) * | 2015-10-27 | 2021-05-26 | ザ ユニバーシティー オブ クイーンズランド | 治療の方法およびそのために有用な剤 |
| CN111259868B (zh) * | 2020-03-10 | 2023-12-12 | 以萨技术股份有限公司 | 基于卷积神经网络的逆行车辆检测方法、系统及介质 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795734A (en) * | 1994-09-19 | 1998-08-18 | President And Fellows Of Harvard College | EPH receptor ligands, and uses related thereto |
| WO1996013518A1 (en) * | 1994-10-27 | 1996-05-09 | Genentech, Inc. | Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor |
| US6057124A (en) * | 1995-01-27 | 2000-05-02 | Amgen Inc. | Nucleic acids encoding ligands for HEK4 receptors |
| WO1996026958A2 (en) * | 1995-02-27 | 1996-09-06 | President And Fellows Of Harvard College | Eph RECEPTOR LIGAND ELF-2 |
| WO1997004091A1 (en) * | 1995-07-20 | 1997-02-06 | Amrad Operations Pty. Ltd. | Novel receptor ligands and genetic sequences encoding same |
| WO1997014966A1 (en) * | 1995-10-13 | 1997-04-24 | Mount Sinai Hospital Corporation | Method of activating a novel ligand regulatory pathway |
| AUPP674898A0 (en) * | 1998-10-27 | 1998-11-19 | Walter And Eliza Hall Institute Of Medical Research, The | A method of treatment |
| NZ553273A (en) | 2004-09-08 | 2009-11-27 | Univ Melbourne | Treating gliosis, glial scarring, inflammation or inhibition of a xonal growth in the nervous system with an antagonist of EphA4-mediated signalling |
-
1998
- 1998-10-27 AU AUPP6748A patent/AUPP674898A0/en not_active Abandoned
-
1999
- 1999-10-27 WO PCT/AU1999/000931 patent/WO2000024413A1/en not_active Ceased
- 1999-10-27 CA CA2346219A patent/CA2346219C/en not_active Expired - Fee Related
- 1999-10-27 EP EP99955594A patent/EP1133309B1/de not_active Expired - Lifetime
- 1999-10-27 AT AT99955594T patent/ATE526980T1/de not_active IP Right Cessation
-
2005
- 2005-04-07 US US11/100,716 patent/US7341997B2/en not_active Expired - Fee Related
-
2008
- 2008-01-14 US US12/007,656 patent/US7897570B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1133309A4 (de) | 2004-09-01 |
| CA2346219A1 (en) | 2000-05-04 |
| US20080255044A1 (en) | 2008-10-16 |
| US7897570B2 (en) | 2011-03-01 |
| WO2000024413A1 (en) | 2000-05-04 |
| EP1133309B1 (de) | 2011-10-05 |
| US7341997B2 (en) | 2008-03-11 |
| US20050181981A1 (en) | 2005-08-18 |
| EP1133309A1 (de) | 2001-09-19 |
| AUPP674898A0 (en) | 1998-11-19 |
| CA2346219C (en) | 2011-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69631134D1 (de) | Verfahren zur bekämpfung infektiöser krankheiten unter verwendung dikationischer bis-benzimidazole | |
| ATE519451T1 (de) | Implantat zur behandlung von bändern und sehnen | |
| DE69829336D1 (de) | Vorrichtung und Verfahren zur Behandlung von Körpergewebe | |
| DE69535498D1 (de) | Verfahren zur behandlung vaskulärer kopfschmerzen | |
| SE9803710D0 (sv) | Use of certain drugs for treating nerve root injury | |
| DE69733132D1 (de) | Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen | |
| DE69942702D1 (de) | Zusammenstellungen und methoden zur behandlung der alzheimerschen krankheit, schäden des zentralnervensystems und entzündlichen erkrankungen | |
| BRPI0006634B8 (pt) | composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios | |
| BR9602485A (pt) | Método para o tratamento da doença de Parkinson composição farmacêutica primeira composição farmacêutica e método para a obtenção de efeito antiParkinson | |
| DE69523074D1 (de) | Verfahren zur behandlung von implantierbaren biologischen geweben zur verringerung von verkalkung | |
| PL336788A1 (en) | Probucol monoesters in treating circulatory system and inflammatory diseases | |
| EP0792156A4 (de) | Verfahren zur vorbeugung oder behandlung von vaskulären hämorragien und der alzheimerischen krankheit | |
| ATE207356T1 (de) | Verwendung von tiagabin zur behandlung von schlafstörungen | |
| ATE411016T1 (de) | Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten | |
| ATE555803T1 (de) | Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen | |
| DE60034871D1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
| AUPP674898A0 (en) | A method of treatment | |
| ATE138567T1 (de) | Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen | |
| ATE422357T1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| ATE260653T1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
| EP1109548A4 (de) | Zusammensetzungen und verfahren zur behandlung und vorbeugung von knochenkrankheiten unter verwendung von tocotrienole | |
| ATA15697A (de) | Vorrichtung zur gewinnung bzw. behandlung von fasern und faserprodukten | |
| DE60136748D1 (de) | Verfahren und zusammensetzungen zur behandlung von augenerkrankungen | |
| DE69638281D1 (de) | Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |